Metabolic biomarkers in cancer

Kacper Szczepski; Inas Al-Younis; Manel Dhahri; Joanna Izabela Lachowicz; Zeyad Al-Talla; Hanan Almahasheer; Noura Salman Alasmael; Mahbuba Rahman; Abdul-Hamid M. Emwas; Lukasz Jaremko; Mariusz Jaremko

doi:10.1016/B978-0-323-99924-3.00005-4

Metabolic biomarkers in cancer

Kacper Szczepski, Inas Al-Younis, Manel Dhahri, Joanna Izabela Lachowicz, Zeyad Al-Talla, Hanan Almahasheer, Noura Salman Alasmael, Mahbuba Rahman, Abdul-Hamid M. Emwas, Lukasz Jaremko, Mariusz Jaremko

Research output: Chapter in Book/Report/Conference proceeding › Chapter

6 Scopus citations

Abstract

Over the course of years healthcare systems have utilized various “-omics” approaches to prognose, diagnose, and evaluate the treatment efficacy of cancer diseases. Metabolomics is one of the latest prominent additions to the -omics approaches, characterized by its versatile methodology. Owing to constant improvements in the field, metabolomics aims to provide a faster and a more accurate diagnosis, as well as personalized and optimal strategies of treatment. In recent years, a growing number of studies have utilized metabolomics approach to find new disease-related biomarkers of cancer diseases. Here we present the summary of recent advances in biomarker discovery for various types of cancers such as leukemia, ovarian, lung, breast, and liver cancers as well as cancer-related cachexia.

Original language	English (US)
Title of host publication	Metabolomics
Publisher	Elsevier
Pages	173-198
Number of pages	26
ISBN (Print)	9780323999243
DOIs	https://doi.org/10.1016/B978-0-323-99924-3.00005-4
State	Published - Jan 27 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-323-99924-3.00005-4

https://repository.kaust.edu.sa/bitstream/10754/678394/3/CH0005_Jaremko_v4_%20MR%20edited%20june272022.pdf

Cite this

@inbook{5cdbc683ee6046968f0278933c625adc,

title = "Metabolic biomarkers in cancer",

abstract = "Over the course of years healthcare systems have utilized various “-omics” approaches to prognose, diagnose, and evaluate the treatment efficacy of cancer diseases. Metabolomics is one of the latest prominent additions to the -omics approaches, characterized by its versatile methodology. Owing to constant improvements in the field, metabolomics aims to provide a faster and a more accurate diagnosis, as well as personalized and optimal strategies of treatment. In recent years, a growing number of studies have utilized metabolomics approach to find new disease-related biomarkers of cancer diseases. Here we present the summary of recent advances in biomarker discovery for various types of cancers such as leukemia, ovarian, lung, breast, and liver cancers as well as cancer-related cachexia.",

author = "Kacper Szczepski and Inas Al-Younis and Manel Dhahri and Lachowicz, {Joanna Izabela} and Zeyad Al-Talla and Hanan Almahasheer and Alasmael, {Noura Salman} and Mahbuba Rahman and Emwas, {Abdul-Hamid M.} and Lukasz Jaremko and Mariusz Jaremko",

note = "KAUST Repository Item: Exported on 2023-02-02 Acknowledgements: We would like to thank King Abdullah University of Science and Technology for financial support.",

year = "2023",

month = jan,

day = "27",

doi = "10.1016/B978-0-323-99924-3.00005-4",

language = "English (US)",

isbn = "9780323999243",

pages = "173--198",

booktitle = "Metabolomics",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Metabolic biomarkers in cancer

AU - Szczepski, Kacper

AU - Al-Younis, Inas

AU - Dhahri, Manel

AU - Lachowicz, Joanna Izabela

AU - Al-Talla, Zeyad

AU - Almahasheer, Hanan

AU - Alasmael, Noura Salman

AU - Rahman, Mahbuba

AU - Emwas, Abdul-Hamid M.

AU - Jaremko, Lukasz

AU - Jaremko, Mariusz

N1 - KAUST Repository Item: Exported on 2023-02-02 Acknowledgements: We would like to thank King Abdullah University of Science and Technology for financial support.

PY - 2023/1/27

Y1 - 2023/1/27

N2 - Over the course of years healthcare systems have utilized various “-omics” approaches to prognose, diagnose, and evaluate the treatment efficacy of cancer diseases. Metabolomics is one of the latest prominent additions to the -omics approaches, characterized by its versatile methodology. Owing to constant improvements in the field, metabolomics aims to provide a faster and a more accurate diagnosis, as well as personalized and optimal strategies of treatment. In recent years, a growing number of studies have utilized metabolomics approach to find new disease-related biomarkers of cancer diseases. Here we present the summary of recent advances in biomarker discovery for various types of cancers such as leukemia, ovarian, lung, breast, and liver cancers as well as cancer-related cachexia.

AB - Over the course of years healthcare systems have utilized various “-omics” approaches to prognose, diagnose, and evaluate the treatment efficacy of cancer diseases. Metabolomics is one of the latest prominent additions to the -omics approaches, characterized by its versatile methodology. Owing to constant improvements in the field, metabolomics aims to provide a faster and a more accurate diagnosis, as well as personalized and optimal strategies of treatment. In recent years, a growing number of studies have utilized metabolomics approach to find new disease-related biomarkers of cancer diseases. Here we present the summary of recent advances in biomarker discovery for various types of cancers such as leukemia, ovarian, lung, breast, and liver cancers as well as cancer-related cachexia.

UR - http://hdl.handle.net/10754/678394

UR - https://linkinghub.elsevier.com/retrieve/pii/B9780323999243000054

U2 - 10.1016/B978-0-323-99924-3.00005-4

DO - 10.1016/B978-0-323-99924-3.00005-4

M3 - Chapter

SN - 9780323999243

SP - 173

EP - 198

BT - Metabolomics

PB - Elsevier

ER -

Metabolic biomarkers in cancer

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this